This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Usefulness of High-frequency QRS Analysis in the Evaluation of Patients With Chest Pain

Sponsored by Ori Galante

About this trial

Last updated 10 years ago

Study ID

sor505310ctil

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 12 years ago

What is this trial about?

Accurate detection of a heart attack (an acute myocardial infarction) is one of the most pressing needs in medicine. Recordings of the electrocardiogram (ECG) (electrical activity of the heart) are one of the first tools used to diagnose a heart attack, but the ECG is not very accurate, especially at the beginning of a heart attack. A new technique for analysing a special part of the ECG may provide more accurate detection of a heart attack. The study hypothesis is that this new technique, the HFQRS analysis, will provide important additional information to that available from the regular ECG.

What are the participation requirements?

Yes

Inclusion Criteria

- Patients with chest pain, suspected to have ACS

- Duration of chest pain greater than 20 minutes

- Time from onset of chest pain less than 12h

- Signed an informed consent

No

Exclusion Criteria

- History of trauma or any other evident medical cause of chest pain

- Prior coronary artery bypass graft

- Pre-excitation syndrome (example WPW)

- Atrial Fibrillation or significant ventricular arrhythmia

- Bundle branch block, intraventricular conduction delay or

- QRS duration greater than 120 ms

- Implanted pacemaker or defibrillator

- Patients who received fibrinolytic therapy, glycoprotein IIb or IIIa inhibitors before the initial ECG recording